Dr. Morton Douglas
Rechtsanwalt
morton.douglas@fgvw.de
T +49 761 21808-307
F +49 761 21808-539
Kaiser-Joseph-Straße 284
79098 Freiburg
Douglas, Morton Dr.
Rechtsanwalt (Lawyer) and Partner
Studied in Freiburg i. Br. and Aberdeen
Focus
Trade Mark and Design Protection: Searches
Developing Strategies for Applications for Registration
Portfolio Advice, Defending Clients in Official and Infringement Proceedings
Licence Agreements, Law of Company Designations, Titles and Domains;
Competition, Advertising Medications, Pharmacy and Drug Law
Crisis Management under Press Law
Languages
German and English
News
Recommendations
Morton Douglas is listed as one of "Germany's Best Lawyers" 2013-2025 in the practice area of intellectual property and competition law (Handelsblatt in cooperation with Best Lawyers)
Recommended lawyer in the field of health (The Legal 500 Germany 2021-2024)
Recommended lawyer for trademark and competition law (The Legal 500 Germany 2016-2024), "very good support and advice on all aspects of trademark law, very professional monitoring of trademarks, very pleasant cooperation"
Frequently recommended for trademark and design law, competition law and the health care sector (JUVE Handbook of German Business Law Firms 2012/2013 - 2024/2025) "competent, very reliable and quick", "very direct, drafts tough court pleadings, but is a helpful colleague in negotiations", "experienced and consistent procedural lawyer", "assertive litigation specialist, especially in pharmaceuticals", "one of the best in his field", "creative solutions, courageous approach", "very experienced and efficient in trademark law"
Recommended for intellectual property - trade marks and unfair competition (The Legal 500 EMEA 2018)
"has in-depth knowledge of the market and attends to a very substantial portfolio", "experience in proceedings before the Office for Harmonisation in Alicante" (Kanzleien in Deutschland, 2012)
Publications
Rückkehr zur grenzüberschreitenden Arzneimittelpreisbindung? (Return to cross-border fixed pharmaceutical prices?), comment on the judgment of the Higher Regional Court of Munich of March 7, 2024, Ref.: 6 U 1509/14, A&R 2024, 122
„Wer hat‘s vertrieben? Zur Abgrenzung zwischen Apotheke und Plattform beim Arzneimittelversandhandel“ (“Who distributed it? On the distinction between pharmacy and platform in the mail-order pharmaceutical trade"), in A&R 2024, 67
- Ross oder Reiter – Zu den Grenzen des Krankenhausprivilegs (On the limits of the hospital privilege), A&R 2023, 75
- Comment on the judgment of the Federal Court of Justice of January 12, 2023, file number IZR22219 I ZR 222/19 and file number I ZR 223/19, A&R 2023, 99 (together with Lukas Kalkbrenner)
- Comment on the judgment of the ECJ of 22.12.2022 (C-530/20), Advertising with special offers for medicinal products, Arzneimittel und Recht (A&R) 2023, p. 38
- Rabatte und Skonti auf Großhandelszuschläge - die Zweite (Discounts and rebates on wholesale surcharges - second part), Arzneimittel und Recht (A&R) 2021, p. 303
- Wenn sich Mitarbeiter weigern - Was Sie zur Corona-Impfung Ihres Personals wissen sollten (When staff refuses - What you should know about Corona vaccination of your staff), Aktueller Wirtschaftsdienst für Apotheker, June 2021, p. 10 et seq. (together with Andreas Schubert)
- Comment on the judgment of the ECJ of October 1, 2020 (Case C-649/18), (together with Anne Bongers-Gehlert), Arzneimittel und Recht (A&R) 2020, p. 235
Grenzen der Zusammenarbeit nach der Neuregelung des Vertriebswegs für Hämophilie-Präparate (Limits of cooperation after the reorganization of the distribution channel for hemophilia preparations), Arzneimittel & Recht, p. 175
- Datenschutz und der Vertrieb apothekenpflichtiger Arzneimittel über Amazon (Data protection and the distribution of pharmacy-only medicines via Amazon), Arzneimittel&Recht 2019, p. 249 (together with Lukas Kalkbrenner)
- Betriebspflicht für nicht rentable Apotheke (Operating obligation for unprofitable pharmacy), comment on the judgment of the Koblenz Higher Regional Court of June 27, 2019 - case no. 1 U 1471/18, Arzneimittel&Recht 2019, p. 278 (together with Ilva Schiessel)
- Wettbewerbsrechtliche Ahndung von DSGVO-Verstößen (Competitive penalty of DSGVO infringements), comment on the judgment of the Hamburg Higher Regional Court of 25.10.2018 - Ref. 3 U 66/17 (together with Lukas Kalkbrenner), Arzneimittel&Recht 2019, p. 35
- Comment on the judgment of the BGH of April 26, 2018 (I ZR 121/17), (together with Anne Bongers-Gehlert), Arzneimittel und Recht (A&R) 2018, p. 268
- Comment on the judgment of the ECJ of March 1, 2018 (C-297/16), (together with Anne Bongers-Gehlert), Arzneimittel und Recht (A&R) 2018, p. 81
- Die datenschutzrechtliche Bewertung der Einbindung von WhatsApp in die Arzneimittelvorbestellung (The data protection evaluation of the integration of WhatsApp into drug pre-ordering), Arzneimittel&Recht 2018, p. 3 (together with Lukas Kalkbrenner)
- Die markenrechtliche Erschöpfung beim Parallelimport von Arzneimitteln [Trade Mark Exhaustion in the case of Parallel Imports of Drugs], published by Carl Heymanns Verlag, 2005